chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache, Myalgia, Fever, NauseaVomiting, stiff neck Narrative:
Diffuse urticaria & swelling on face, trunk, bilateral upper & lower extremities and hoarseness/throat tightening.
Tingling and pinching on both hands/fingers; Numbness; Blisters on tips of fingers; Bruising under nails.; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM6199) via an unspecified route of administration in the left arm on 06Mar2021 at 13:45 (at the age of 42-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 27Mar2021 at 14:45 (at the age of 42-years-old) as single doses for COVID-19 immunisation. Medical history included diabetes type 2. The patient did not have any allergies to medications, food, or other products. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 06Mar2021 at 17:30, the patient experienced tingling and pinching on both hands/fingers also numbness, blisters on tips of fingers and bruising under nails. The adverse events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. Therapeutic measures were taken as a result of events tingling and pinching on both hands/fingers, numbness, blisters on tips of fingers and bruising under nails which included treatment with prednisone (MANUFACTURER UNKNOWN) and cetirizine (MANUFACTURER UNKNOWN). The clinical outcomes of the events tingling and pinching on both hands/fingers, numbness, blisters on tips of fingers and bruising under nails were not resolved at the time of the report.   No follow-up attempts are needed. No further information is expected.
Had headache with first dose, with second one headache more severe Strong stomach upset Bedridden with fatigue Hot/cold (hands and feet icy)
Initial consumer report received on 03 Dec 2009: This patient received FLUVIRIN on an unknown date. The patient stated that "she thinks that she may have got almost 3 times the 0.5 ml dose." The patient could not confirm the amount administered. The outcome was not reported.
Resident was vaccinated.  Pt was admitted on 6/28 with dx of pneumonia, cdiff and sepsis. On admission pt noted to have dry cough and lethargy. Pt had signs of aspiration and dyspnea and was sent to ED for evaluation within five hours of admission to Beecher Manor.  She was treated for aspiration pneumonia w/diagnosis of pneumonitis r/t food and vomit. She was re-admitted to Beecher Manor  on 7/3 with orders for Augmentin PO 7/4 - 7/9. She continued to decline w/plans by family to begin Hospice care. She expired during process of initiating hospice care.
Patient is an 18 year old female A & O x4 with chief complaint of feeling light headed and dizzy.  Patient was sitting in the observation area and began experiencing symptoms when she saw another patient have a syncopal episode.  Patient was placed in a seated position and vital signs obtained.  Vital signs stable and patient denied any other complaint.  Patient denied any medical history, allergies and took prophylactic ibuprofen prior to coming to the vaccine. Medical staff already on scene immediately assumed patient care.  Patient signed AMA and went home driven by a friend via private vehicle.
Nerve pain across front and back of torso, blisters along nerve trunks.  Diagnosed as shingles.  Toradol injection, oral prednisone, and Franchville prescribed.
Five minutes after receiving injection patient experienced shortness of breath, itching and burning in left arm and hand, right arm.  She reported taking 2 puffs of her Proair inhaler.  She worried she would pass out as she was walking.  She reported her condition to NP who did an assessment.  At 9:40AM the patients vitals were BP: 147/104, HR=109, O2=98%,  She was advised to lie down and was placed under observation for 15 minutes.  Vitals were taken again at 9:55AM - BP=142/92, HR=103, O2=95%.  The patient moved to the Travel, Immunization, and Allergy Clinic for further observation.  Dr. examined the patient.  He Heart rate was 116.  The patient drank some water and juice and took an antihistamine (Claritin).  She didn't want Benadryl as she didn't like the way it made her sleepy.  After resting for 40 minutes, she stated that she felt better.  Dr. checked on her again and said that she could go back to work if she felt OK and to be monitered by RN for the next hour.  She rested and was checked at 10:30, 11:00, 11:30 AND 12:15 and reported feeling better.
Pt projectile vomited and was irritable for a couple days after the vaccines were administered.  About a month after the vaccines were administered, he seemed to have intense abdominal pain each time he fed (I was breast feeding at the time).  Each time I fed him, he would straighten his body out and scream in pain.  We had him seen by a pediatric gastroenterologist who did many tests and she concluded he developed gastritis and was now lactose intolerant.  So we put him on a soy formula which he continued to refuse.  He never did take a bottle.  We eventually had to feed him through a syringe.  The first three months of his life he was in the 95% in weight and height and he dropped down to the 25% in weight.  All this didn't concern the doctors and they didn't think that the vaccines caused these symptoms.  We beg to differ.
Woozy and stumbled that evening.  Next day extreme body aches and fatigue requiring bed rest.  Same for the day after (Sunday).  Bedridden for majority of the two days after second dose of vaccine.  Miserable suffering.   I've experienced the flu with a sinus infection.  This felt more than twice as bad.
a patient, who has AIDS, received a dose of VARIVAX on 1/16/2020. Physician reported the patient had a "CD4 count of 159" prior to receiving dose of VARIVAX.; This spontaneous report was received from a physician referring to a patient of unknown age and gender. Concurrent condition included acquired immune deficiency syndrome (AIDS). Information about medical history, drug reaction/allergy and concomitant medication was not provided.       On an unknown date prior to receiving dose of varicella virus vaccine live (oka/merck) (VARIVAX), the patient's cluster of differentiation 4 (CD4) count was 159 (unit not provided). On 16-JAN-2020, the patient who had AIDS was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) (lot # S005084, expiration date not reported, but upon internal validation established as 19-FEB-2021; strength, vaccine dosage detail and route of administration were not reported) for prophylaxis (product use in unapproved population).    The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT. The outcome of the event was unknown.
9-14-13 Patient erroneously received anthrax vaccine subcutaneously instead of PPD at immunization clinic in August 2013. It has been 1 month and he has small 7mm nodule on left forearm where anthrax vaccine was given. Patient told to let us know if it causes him any problems. 2-8-14 Patient received anthrax vaccine 6 months ago. No issues since that time - had a small nodule at the site - now only has slight hyperpigmentation - no nodule. Over last week or so patient noted rash on b/l lower extremities. Somewhat itchy, no pustules. Has a "HA" off and on, but no other sx of URI, fever, pain etc. O: Gen. alert, WD/WN NAD. (L) arm: 3 mm circular area of hyperpigmentation on forearm. Lower ext: mult. excoriated eryth. or scabbed discrete lesions of various sizes. No pustules, no ulceration. A/P: Rash. New onset rash - don't think related to anthrax. Recommended topical abx and bleach baths. If no improvement should f/u w/ primary care.
Got the shot and while we were waiting i just realized at my collar bone and my breast it felt really tight.  and around 2 pm i felt a little burn at my color bone there was two little spots that looks like bites and went and took nap and when i woke up i was fine. do have sore arm and not able to lift it high.
became extremely irritable; t102.6 in ER; took pt to ER given Ibuporfen temp came down 101.6; pt exp unconsolable crying for 10-11 hrs;
Forgetting things began Sunday, coughing tightness in chest, spasms in right arm, chills exhaustion, loose bowels. Temp and BP ok.
Vaccine failure in a pregnant woman.  Primary cesarean section at term for failure to progress - resulted in live birth. Patient received H1N1 vaccine approximately 2 months prior to symptom onset. Patient admitted 2/25/2010 Urgent endotracheal intubation 2/28/2010, respiratory failure with frequent desaturation
Pain to shoulder that's become chronic in nature. Diagnosed as impingement syndrome involving rotator cuff tendons and deltoid muscle inflammation.
Patient experienced hypertension, dizziness, nausea, thick secretions in throat, and itchy throat. Was treated with a single dose of Dexamethasone 10 mg IV. Symptoms resolved and patient was sent home.
Severe left hip inflammation causing extreme stabbing pain and difficulty walking or standing within 24 hours of vaccination.  Took 2 Norco for pain relief with moderate symptom relief. Right knee pain as well but not as severe.
Pt stopped responding and looked pale at first site. Patient was clammy, and shaking. Patient c/o nausea and feeling lethargic, visual changes- "everything is yellow".
temperature is 98.8 F today and usually it is always 97.3 F; This is a spontaneous report from a contactable consumer (Patient). A male patient of an unspecified age received first dose and second dose of BNT162B2 (COMIRNATY, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was Unknown) as single dose for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. Patient reported that his temperature was 98.8 F today and usually it is always 97.3 F. The patient wanted to know if what he was experiencing was a breakthrough infection or unusual side effects after getting two doses of the Pfizer-BioNTech covid-19 vaccine. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Case number PHHY2015US068689 is an initial spontaneous report received on 03 Jun 2015. The author discussed about the safety profile of pregnancy exposures to the quadrivalent human papillomavirus vaccine (qHPV) by acquiring and analyzing post marketing data on pregnancy outcomes from GARDASIL/SILGARD pregnancy registry. The registry enrollment criteria included an identifiable patient, exposure to HPV vaccine within one month prior to the date of onset of last menstrual period (LMP) or at any time during pregnancy, identification of health care provider and residency in a country where the registry was active. This report refers to an 18 year old pregnant female patient. Her medical history and concomitant medications were not reported. She was vaccinated with qHPV (other manufacturer, batch number: not reported) on an unknown date. It was reported that exposure to HPV vaccine occurred 1 week and 5 days from LMP. She concomitantly received influenza virus vaccine (manufacturer and batch number: not reported), ferrous sulphate (unknown manufacturer) and cannabis (unknown manufacturer) at 8 to 9 weeks of gestation. She had twin gestation delivered at 32 to 33 weeks of gestation. The death of first twin was diagnosed at 28 weeks and it was approximately 22 weeks by size at delivery (fetal death at 22 weeks of gestation). There were no abnormalities on autopsy. The second twin was born live with no abnormalities (see related case number: PHHY2015US069160). The author concluded the article stating that the rates of spontaneous abortions and major birth defects were not greater than the general population rates. Due to the nature of voluntary spontaneous reporting, no definitive conclusions could be made about the potential effects of exposure to qHPV vaccine during pregnancy and hence qHPV vaccine was not recommended for use in pregnant women.
Information has been received from a registered nurse concerning a 68 year old male with asthma and a Naproxen allergy who on 1/20/2006 was vaccinated SC with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 650453/0791P). there was no concomitant medication. On 1/21/2006 within 24 hours, the patient experienced swelling, redness and pain in the site and went down the patients arm to the wrist. Unspecified medical attention was sought. It was noted that the patient was unable to work for 3 days, Three or four days later, the symptoms subsided and the patient recovered. No product quality complaint was involved. Swelling, redness and pain at the site and went down the patients arm to the wrist were considered to be disabling. Additional information has been requested.
PATIENT STATED HAVING CHILLS AND COULD NOT WARM UP. SHE HAD A FEVER OVER 100. PT STATED THAT BY 11/14/20 SHE FELT FINE OTHER THAN HER ARM WAS SORE AND BACK WAS ITCHING. HUSBAND STATED THAT PT'S BACK WAS COMPLETELY BROKEN OUT IN RASH. DR RECOMMENDED PATIENT TO TAKE BENADRYL AND MONITOR SYMPTOMS. PT STATES SHE TOOK THE BENADRYL, RASH IS SOME BETTER BUT STILL THERE, SHE WILL CONTINUE TO MONITOR SYMPTOMS AND NOTIFY US IF THINGS GET WORSE.
Information has been received from a certified medical assistant concerning a female patient who was vaccinated intramuscularly in the right arm with a dose of pneumococcal 23v polysaccharide vaccine (lot 631319/1007P).  Subsequently she developed a red, warm, swollen arm at the injection site.  It was also reported that she developed a "cellulitis type reaction" and fever.  The patient sought medical assistance and was recovering at the time of the report.
April 14 vaccination; April 15 chills, nausea, vomiting; April 24-May 1 leg paresthesias; April 29 upper body post exertional maalaaise following activities of daily living; May 1 subtle paresthesias in hands arms, start of period; May 1-8 paresthesias resolve with aid of 250mg magnesium, post exertional malaise continues, muscle weakness in abs and legs gradually worsens; May 8 can't walk back from mail box, call husband for ride, arm and neck weakness; May 10 parents arrive, take over child/house care; May 11 PCP appointment, Neurologist and MRI referral; May 14 bed ridden with muscle weakness, need help eating/brushing teeth etc.; May 15-18 mobility allows for movement around house; May 19 MRI; May 21 MRI results benign, muscle weakness persists, allowing for low levels of mobility around house but continued need for help with child care and household chores. Self-administered daily medications: Vitamin D 8,000, CoQ10, magnesium 250 mg, ibuprofen 600-800 mg
Vaccination in A.M. of 10/26/06.  Reaction to pneumococcal polysaccharide vaccine.  Specific vaccine information unknown to patient.  Red inflammation up to 3" diameter as of 10/29/06; temp. to 102F; swelling and soreness in arm where vaccination was administered; treatment recommended: (10/28/06-1st visit) ice pack, tylenol/motrin rotation, lortab; (10/29/06-2nd visit) hot pack, bactrim.
11 Days after vaccine, three small, welt like red spots appeared at the injection site and the next day one large red area.  The next day the size of redness increased up to shoulder area in circular pattern. Area was swollen and warm to the touch. No fever.
Rash developed on upper left arm ( not the arm I received the vaccine injection)   It is a urticaria rash in 4- 5 sites on my left arm.   It is itchy and has small blisters .   It is responding slowly  to topical creams.
DIZZY VS 4:41 O2  99% HR 76 BP 100/74
Severe abdominal pain (lasting 7 days, hospitalized every month since October), low blood pressure (80/74),high heart rate (162), Admitted to ICU on last visit to hospital (1/22) Numbness in left leg and foot. Unofficially diagnosed with Porphyria.
Information has been received from a nurse, via a company representative, concerning a 34 year old female patient, who on 09-SEP-2006 was vaccinated with the first dose, 0.5ml, of Gardasil (Lot #653937/0637F). Concomitant therapy included Loestrin and Detrol LA. The nurse reported that after the vaccine was administered (date unspecified), the patient "experienced tingling and numbness in most areas of her body." On an unspecified date, the patient received her second dose, 0.5 ml, IM, of Gardasil (Lot #653938/0954F), and had a recurrence of the numbness and tingling in her body. On 20-MAR-2007, the patient received her third dose, 0.5ml, IM, of Gardasil (Lot #655849/0263U), and once again had a recurrence of the numbness and tingling in her body (date unspecified). A magnetic resonance imaging test was performed (date unspecified), and was negative. At the time of this report, the nurse confirmed that the patient had not recovered. Additional information has been requested. 6/27/07-records received for DOS 3/27/07-6/15/07-On 3/27/07-presented with bilateral leg pain, numbness and tingling. No strength issues.  Seeing neurologist. Note on 4/26/07-suspect restless leg syndrome for her migratory sensory discomfort in all 4 limbs and torso. Neuro exam did not show peripheral neuropathy. Note on 6/20/07-Sensory 85%  better.
Numbness to face and lips, chest tightness and sensation of swelling to back of tongue.   Given Benadryl 50 mg PO and subsequently EpiPen .
Leg red and swollen at site of injection yesterday evening and early AM fever. Pt given Zyrtec to take.
Full body itching for several days  Fatigue Body aches Headaches  Had Covid in mid January 2021
Patient felt flushed and light headed/dizzy, was given water and Benadryl, recovered in 30 minutes and went home after being observed for an additional 15 minutes
BONES HURTING BAD ALL OVER (WORSE AT LEGS AND BOTH SHIN BONE PAIN); SLEEPY; NAUSEA; VOMITING; This spontaneous report received from a patient concerned a 57 year old female. The patient's weight was 105 pounds, and height was 50 inches. The patient's concurrent conditions included non-smoker, and drink alcohol socially, and other pre-existing medical conditions included the patient had no known allergies and no drug abuse or illicit drug usage. the patient had not been vaccinated since 5 years of age.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and expiry: 13/JUN/2021) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 01-APR-2021, the subject experienced vomiting. On 02-APR-2021, the subject experienced sleepy. On 02-APR-2021, the subject experienced nausea. On 05-APR-2021, the subject experienced bones hurting bad all over (worse at legs and both shin bone pain). Laboratory data (dates unspecified) included: Blood test (NR: not provided) thyroid levels were normal. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from bones hurting bad all over (worse at legs and both shin bone pain), nausea, vomiting, and sleepy. This report was non-serious.
only 14 days between 1st and 2nd dose. 1st dose given 9/9/2021. Patient had denied having first dose until discharge, then retrieved card from car showing 1st dose 9/9/2021. No adverse event noted.
Patient states she now has a noninvasive encapsulated pancreatic tumor that is pressing against her bile duct and she has not had any issues before adn this appeared after her second moderna vaccine
Child experienced hyper activity early in the morning until PM with stuffy nose, runny nose and cough in the afternoon.   The child experienced hyper activity the after the first shot (11/6/09); however, no other cold symptoms.
This spontaneous report as received from a nurse refers to an unknown number of patients of unknown age and gender. Medical history and drug reactions or allergies were not specified. On unknown dates, reported as since December 2013, the patients were possibly administered doses of (Oka/Merck) PROQUAD injection (dose, route and lot number were not reported) which were not stored properly. No adverse effects were noted. Concomitant medications were not specified. This is one of several reports received from the same reporter. Additional information has been requested.
Excruciating Pain in lower back.left hip, and thigh; Excruciating Pain in lower back.left hip, and thigh; Excruciating Pain in lower back.left hip, and thigh; This is a spontaneous report from a contactable consumer (patient). An 80-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL 9267), via an unspecified route of administration, administered in Arm Right on 12Feb2021 02:30 (age at vaccination 80-year-old) as single dose for COVID-19 immunisation. Medical history included broken right hip and femur, osteoporosis, both knee replacement. The patient had no COVID prior vaccination. Concomitant medications included Epidural Steroid. RF. SI Joint, Hip, Knee, or Facet Bl in two weeks. The patient did not receive any other vaccine in four weeks. The patient previously received penicillin, alopurinol and experienced allergy. On 13Feb2021 02:30 AM, the patient experienced excruciating pain in lower back. left hip, and thigh. The patient received treatment with Advil. The patient had not tested COVID post vaccination. Outcome of the events were recovering.  Follow-up attempts completed. No further information expected.
local rxn that was sore, swollen, hot to touch & diff lifting arm; area 6" x 4"; much better as of 5OCT94 but a little sore; probably had last dose in 1984
Myalgia Narrative: bilateral lower ext leg pain starting day of Moderna booster alleviated w nsaids returning when nsaids not used. present today 5 weeks later.